Home › Funds › CPMG Inc › PRCT
CPMG Inc position in PRCT
PROCEPT BIOROBOTICS CORP · Health Care
CPMG Inc reported holding 426,262 shares of PRCT (PROCEPT BIOROBOTICS CORP) in its Q1 2026 13F filing — a position valued at US$10.7M, representing 28.75% of its reported portfolio and ranking #2 among its reported holdings. CPMG Inc has disclosed PRCT holdings in 5 of the last 11 reported quarters, going back to Q3 2023.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How CPMG Inc's PRCT position evolved
CPMG Inc first disclosed a stake in PRCT in Q3 2023 at 5,328,867 shares (US$174.8M). The position peaked in Q1 2024 at 5,328,867 shares, worth US$263.4M. Across 5 filings, CPMG Inc increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q1 2026) shows 426,262 shares valued at US$10.7M. Notable position changes include a 82% trim in Q3 2024 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 5.33M | $174.84M | New |
| Q4 2023 | 5.33M | $223.33M | Hold |
| Q1 2024 | 5.33M | $263.35M | Hold |
| Q3 2024 | 958.33K | $76.78M | Reduce |
| Q1 2026 | 426.26K | $10.66M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PRCT and 13F data
PRCT (PROCEPT BIOROBOTICS CORP) is a Health Care company. 18 other funds we track also report a position in PRCT — the largest reported positions include Soleus Capital Management, L.P. (US$22.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PRCT
- Soleus Capital Management, L.P. 1.00M sh · $22.65M · Q2 2026
FAQ
How long has CPMG Inc held PRCT?
CPMG Inc has disclosed PRCT holdings in 5 of the last 11 reported quarters, going back to Q3 2023.
What is CPMG Inc's current position in PRCT?
As of Q1 2026, CPMG Inc holds 426.26K shares of PRCT (PROCEPT BIOROBOTICS CORP), valued at $10.66M, representing 28.75% of its reported portfolio and ranking #2.
Has CPMG Inc been buying or selling PRCT?
In the latest 13F filing (Q1 2026), CPMG Inc newly opened its position in PRCT. The position peaked in Q1 2024 at 5.33M shares.
Which other funds hold PRCT?
Other major institutional holders of PRCT include Soleus Capital Management, L.P., among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.